Literature DB >> 351979

Dextran in the prophylaxis of pulmonary embolism.

S E Bergentz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 351979     DOI: 10.1007/bf01574452

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  32 in total

1.  Postoperative venous thrombosis in benign prostatic disease. A study of 316 patients, using the 125I-fibrinogen uptake test.

Authors:  P O Hedlund
Journal:  Scand J Urol Nephrol       Date:  1975

2.  Heparin versus dextran in the prevention of deep-vein thrombosis. A multi-unit coctrolled trial.

Authors: 
Journal:  Lancet       Date:  1974-07-20       Impact factor: 79.321

3.  Leg vein thrombosis diagnosed by 125 I-fibrinogen test in patients with fracture of the hip: a study of the effect of early prophylaxis with dicoumarol or dextran 70.

Authors:  D Bergqvist; S Dahlgren
Journal:  Vasa       Date:  1973       Impact factor: 1.961

4.  Prevention of thrombosis after pelvic surgery by British dextran 70.

Authors:  J Bonnar; J Walsh
Journal:  Lancet       Date:  1972-03-18       Impact factor: 79.321

5.  Deep venous thrombosis after major operations.

Authors:  E Korvald; E J Storen
Journal:  J Oslo City Hosp       Date:  1973 Jun-Jul

6.  Prevention of thromboembolic disease after elective surgery of the hip.

Authors:  C M Evarts; E J Feil
Journal:  J Bone Joint Surg Am       Date:  1971-10       Impact factor: 5.284

7.  Dextran 70 in prophylaxis of thromboembolic disease after surgery: a clinically oriented randomized double-blind trial.

Authors:  A Kline; L E Hughes; H Campbell; A Williams; J Zlosnick; K G Leach
Journal:  Br Med J       Date:  1975-04-19

8.  Dextran 75 and postoperative phlebitis. Evaluation of dextran 75 in the prophylaxis of postoperative thrombophlebitis, pulmonary embolism, and myocardial infarction.

Authors:  J W Hartshorn; S N Teale; M Faiz
Journal:  Arch Surg       Date:  1969-06

9.  Effect of dextran on factor VIII (antihemophilic factor) and platelet function.

Authors:  M Aberg; U Hedner; S E Bergentz
Journal:  Ann Surg       Date:  1979-02       Impact factor: 12.969

10.  A comparative study of dextran-70, warfarin and low-dose heparin for the prophylaxis of thrombo-embolism following total hip replacement.

Authors:  H M Barber; E J Feil; C S Galasko; D H Edwards; R A Sutton; D W Haynes; G Bentley
Journal:  Postgrad Med J       Date:  1977-03       Impact factor: 2.401

View more
  6 in total

Review 1.  Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group.

Authors: 
Journal:  BMJ       Date:  1992-09-05

2.  The use of blood components in surgical transfusion therapy.

Authors:  C F Högman; L Bagge; L Thorén
Journal:  World J Surg       Date:  1987-02       Impact factor: 3.352

Review 3.  The use of plasma substitutes with special attention to their side effects.

Authors:  K F Messmer
Journal:  World J Surg       Date:  1987-02       Impact factor: 3.352

4.  New clinico-pathophysiological studies on the bone cement implantation syndrome.

Authors:  H Rinecker
Journal:  Arch Orthop Trauma Surg       Date:  1980

5.  Effect of dextran on platelet activation by polymerizing fibrin.

Authors:  C H Ts'ao; D V Krajewski
Journal:  Am J Pathol       Date:  1982-01       Impact factor: 4.307

6.  Incidences of fatal postoperative pulmonary embolism after prophylaxis with dextran 70 and low-dose heparin: an international multicentre study.

Authors:  U F Gruber; T Saldeen; T Brokop; B Eklöf; I Eriksson; I Goldie; L Gran; M Hohl; T Jonsson; S Kristersson; K G Ljungström; T Lund; H M Moe; E Svensjö; D Thomson; J Torhorst; A Trippestad; M Ulstein
Journal:  Br Med J       Date:  1980-01-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.